What Is Old Is New Again: Delafloxacin, A Modern Fluoroquinolone
ISBN or ISSN
Date of original Performance / Presentation
Publication Date / Copyright Date
John Wiley & Sons, Inc.
Delafloxacin is a new fluoroquinolone antimicrobial approved for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) in adults using dosage regimens of 300 mg intravenously every 12 hours, 450 mg orally every 12 hours, or switching from intravenous to oral regimens for a 5- to 14-day treatment duration. Dosage adjustments in patients with severe renal dysfunction (estimated glomerular filtration rate [eGFR] = 15-29 ml/min/1.73 m
Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences
administration, adult, anti-bacterial agents, bacterial, fluoroquinolones, gram-negative bacteria, gram-negative bacterial infections, gram-positive bacteria, gram-positive bacterial infections, humans, intravenous, oral, skin diseases
Cho, Jonathan C; Crotty, Matthew P; White, Bryan P; and Worley, Marylee V., "What Is Old Is New Again: Delafloxacin, A Modern Fluoroquinolone" (2018). Faculty Articles. 62.